Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunogenicity and safety of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Taiwan.
Lin TY, Lu CY, Chang LY, Chiu CH, Huang YC, Bock HL, Tang H, François N, Moreira M, Schuerman L, Huang LM. Lin TY, et al. Among authors: bock hl. J Formos Med Assoc. 2012 Sep;111(9):495-503. doi: 10.1016/j.jfma.2011.07.014. Epub 2012 Mar 18. J Formos Med Assoc. 2012. PMID: 23021506 Free article. Clinical Trial.
A new measles mumps rubella (MMR) vaccine: a randomized comparative trial for assessing the reactogenicity and immunogenicity of three consecutive production lots and comparison with a widely used MMR vaccine in measles primed children.
Lee CY, Tang RB, Huang FY, Tang H, Huang LM, Bock HL. Lee CY, et al. Among authors: bock hl. Int J Infect Dis. 2002 Sep;6(3):202-9. doi: 10.1016/s1201-9712(02)90112-8. Int J Infect Dis. 2002. PMID: 12718836 Free article. Clinical Trial.
Reactogenicity and immunogenicity of reduced antigen content diphtheria-tetanus-acellular pertussis vaccine (dTpa) administered as a booster to 4-6 year-old children primed with four doses of whole-cell pertussis vaccine.
Kosuwon P, Warachit B, Hutagalung Y, Borkird T, Kosalaraksa P, Bock HL, Poovorawan Y. Kosuwon P, et al. Among authors: bock hl. Vaccine. 2003 Oct 1;21(27-30):4194-200. doi: 10.1016/s0264-410x(03)00496-1. Vaccine. 2003. PMID: 14505898 Clinical Trial.
152 results